EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 28-Apr-2025 22:08 ET (29-Apr-2025 02:08 GMT/UTC)

Immune cell research identifies potential new target for treating cancer and autoimmune disease

Johns Hopkins Medicine
Peer-Reviewed Publication

In a study of the immune systems of mice, scientists at Johns Hopkins Medicine say they have found a new role for a protein, QRICH1, which could become a target for drugs to dial up or down the activation of T cells to fight cancers and autoimmune diseases.

Journal: Science Immunology
Funder: NIH/National Institutes of Health, NIH/National Institutes of Health, NIH/National Institutes of Health

William N. Hait, MD, Ph.D., FAACR, honored with the 2025 AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research

American Association for Cancer Research
Grant and Award Announcement

The 2025 AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research will be presented to William N. Hait, MD, PhD, Fellow of the AACR Academy, during the AACR Annual Meeting 2025, to be held April 25-30 at the McCormick Place Convention Center in Chicago, Illinois.

Meeting: AACR Annual Meeting 2025

USPSTF recommendation statement on primary care behavioral counseling interventions to support breastfeeding

JAMA Network
Peer-Reviewed Publication

Bottom Line: The U.S. Preventive Services Task Force (USPSTF) recommends providing interventions or referrals, during pregnancy and after birth, to support breastfeeding. The association between breastfeeding and health benefits in children has been previously well established; health benefits have also been found for women who breastfeed. However, breastfeeding rates in the U.S. are relatively modest; as of 2021, 59.8% of infants at age 6 months are breastfed and 27.2% of infants at that age are exclusively breastfed. The USPSTF routinely makes recommendations about the effectiveness of preventive care services and this recommendation updates and is consistent with the 2016 recommendation statement on primary care interventions to support breastfeeding.

Journal: JAMA

NRG Oncology adds new sarcoma subcommittee to organization, appoints new vice-chair for imaging committee

NRG Oncology
Business Announcement

NRG Oncology (NRG), a National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced the creation of a new Sarcoma Subcommittee, as well as a new Vice-Chair for the group’s Imaging Committee.

Dana-Farber nurses present research at 2025 Oncology Nursing Society Congress

Dana-Farber Cancer Institute
Meeting Announcement

Dana-Farber Cancer Institute nurse scientists and clinicians are presenting key studies at the 50th annual Oncology Nursing Society (ONS) Congress taking place from April 9-13, 2025, in Denver.

AI that measures its own uncertainty could improve liver cancer detection

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY – April 8, 2025 – A new editorial was published in Oncotarget, Volume 16, on April 4, 2025, titled “Deep learning-based uncertainty quantification for quality assurance in hepatobiliary imaging-based techniques.”

Journal: Oncotarget

City of Hope study demonstrates proof of concept for targeted new approach to treat pancreatic cancer

City of Hope
Peer-Reviewed Publication

Researchers at City of Hope have identified a new molecular target for treating pancreatic cancer, reports a Gastroenterology study published today. Led by Mustafa Raoof, M.D., M.S., City of Hope assistant professor of surgery, cancer genetics and epigenetics, scientists focused on transcription-replication conflicts (TRCs), which occur when the mechanisms responsible for gene expression and genome duplication collide. The clash disrupts cells’ ability to read and copy genes, leading to replication stress, a frequent phenomenon in pancreatic cancer. The added stress causes cells to make errors copying their DNA, enabling cancer to gain a foothold and spread. Overall, the experimental approach was most effective at killing cancer cells with high replication stress, a common phenomenon that occurs when the KRAS gene goes awry.

Journal: Gastroenterology
Funder: National Comprehensive Cancer Network, 2020 Pancreatic Cancer Action Network Career Development Award in Memory of Skip Viragh, NIH/National Cancer Institute, NCCN Foundation

Cancer-fighting implant shows promise in treating melanoma, pancreatic and colorectal tumors

Rice University
Peer-Reviewed Publication

A team of researchers from the Rice Biotech Launch Pad at Rice University has developed an implantable “cytokine factory” that safely triggers potent immune responses against hard-to-treat cancers, including metastatic melanoma, pancreatic and colorectal tumors.

Journal: Journal for ImmunoTherapy of Cancer
Funder: Avenge Bio, Cancer Prevention Research Institute of Texas, NIH/National Institutes of Health, Advanced Research Projects Agency for Health

Singapore scientists pioneer non-invasive 3D imaging to transform skin cancer management

Agency for Science, Technology and Research (A*STAR), Singapore
Peer-Reviewed Publication

Researchers from the Agency for Science, Technology and Research (A*STAR) and the National Healthcare Group (NHG) have jointly pioneered an innovative imaging technique combining Multispectral Optoacoustic Tomography (MSOT) with artificial intelligence (AI) that could significantly improve the diagnosis and treatment of basal cell carcinoma (BCC), the most common form of skin cancer worldwide.

Journal: European Journal of Nuclear Medicine and Molecular Imaging

Powerful new tool promises major advances in cancer treatment

University of South Australia
Grant and Award Announcement

New Australian technology is set to transform the way that gastrointestinal cancers are detected and treated with precise, minimally invasive surgery.

Funder: Australian Government

25
26
27
28
29